Mass General Brigham Cancer Institute — Boston, Massachusetts

Mass General Brigham Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Mass General Brigham Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumors, Ewing Sarcoma, Hepatocellular Carcinoma (HCC).

Sponsors: SEED Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass General Brigham Cancer Institute?

Mass General Brigham Cancer Institute has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass General Brigham Cancer Institute conducted?

Mass General Brigham Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumors, Ewing Sarcoma, Hepatocellular Carcinoma (HCC).

Is Mass General Brigham Cancer Institute accredited by Crixeo Health?

Mass General Brigham Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mass General Brigham Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.